logo

ARMP

Armata Pharmaceuticals·AMEX
--
--(--)
--
--(--)

ARMP fundamentals

Armata Pharmaceuticals (ARMP) released its earnings on Aug 12, 2025: revenue was 2.17M (YoY --), beat estimates; EPS was -0.45 (YoY -80.00%), missed estimates.
Revenue / YoY
2.17M
--
EPS / YoY
-0.45
-80.00%
Report date
Aug 12, 2025
EPS
Q2,undefined
Q4,undefined
Q1,2018
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.49-0.26-0.31-0.36-0.27-0.25-0.22-0.23-0.3-0.26-0.24-0.29-0.4-0.17-0.86-0.55-0.69-0.25-0.15-0.23-0.2-0.45
Forecast
-0.295-0.32-0.2033-0.0975-0.235-0.205-0.2333-0.24-0.165-0.19-0.22-0.215-0.25-0.295-0.255-0.285-0.31-0.37-0.28-0.35-0.38-0.39
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-66.10%
+18.75%
-52.48%
-269.23%
-14.89%
-21.95%
+5.70%
+4.17%
-81.82%
-36.84%
-9.09%
-34.88%
-60.00%
+42.37%
-237.25%
-92.98%
-122.58%
+32.43%
+46.43%
+34.29%
+47.37%
-15.38%
Revenue
Q2,undefined
Q4,undefined
Q1,2018
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
--------------------500.00K31.00K288.00K504.00K1.07M1.17M1.25M989.00K1.24M1.88M1.34M1.05M796.00K980.00K1.23M1.53M966.00K02.97M1.24M491.00K2.17M
Forecast
--------------------500.00K750.00K875.00K270.67K0410.00K1.08M775.00K975.00K1.13M1.64M1.67M1.75M1.80M950.00K840.00K1.10M1.15M900.00K1.56M1.38M1.38M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-95.87%
-67.09%
+86.21%
0.00%
+184.88%
+16.32%
+27.61%
+26.77%
+67.38%
-18.41%
-37.07%
-54.51%
-45.56%
+28.95%
+81.90%
-12.18%
-100.00%
+230.33%
-20.83%
-64.42%
+57.17%

Earnings Call